PCRX

NASDAQ 已收盘

Pacira BioSciences, Inc.

27.62 USD
+0.51+2.60%
2026-08-03
市值
$1.09B
市盈率
78.52
EPS
0.12
股息率
52 周区间
18.80 – 27.64
成交量
1.13M
Beta
0.27
目标价
29.67
52W 低 18.8052W 高 27.64
价格走势

公司简介

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled dos...